Clinical Trial Update: Etoricoxibe - Preemptive and Postoperative Analgesia for Abdominal and Thoracic Surgery [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating etoricoxib for preemptive and postoperative analgesia in abdominal and thoracic surgery has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• Etoricoxib (etoricoxib)

Snippet

Sponsor: Ludwig-Maximilians - University of Munich | Conditions: Pain, Abdominal Surgery | Phase 3 | Status: TERMINATED